title: First generation stochastic gene episilencing (step1) model and applications to in vitro carcinogen exposure.
abstract: A novel first-generation stochastic gene episilencing (STEP1) model is introduced for quantitatively characterizing the probability of in vitro epigenetically silencing (episilencing) specific tumor-suppressor-microRNA (miRNA) genes by carcinogen exposure. Although the focus is mainly on in-vitro exposure of human cells to ionizing radiation, the mathematical formulations presented are general and can be applied to other carcinogens. With the STEP1 model, a fraction fj of the surviving target cells can have their tumor-suppressor-miRNA gene of type j silenced while the remaining fraction, 1 - fj , of the surviving cells do not undergo gene episilencing. Suppressor gene episilencing is assumed to arise as a Poisson process characterized with and exponential distribution of episilencing doses with mean dj . In addition to providing mathematical functions for evaluating the single-target-gene episilencing probability, functions are also provided for the multi-target-gene episilencing probability for simultaneously silencing of multiple tumor-suppressor-miRNA genes. Functional relationships are first developed for moderate doses where adaptive responses are unlikely and are then modified for low doses where adaptation can occur. Results apply to a specific follow-up time t after carcinogen exposure that exceeds the maximum time for the occurrence of an induced episilencing event.
authors.affiliation: Lovelace Respiratory Research Institute.
authors.forename: Bobby R
authors.initials: BR
authors.lastname: Scott
keywords: epigenetic; microRNA; model; radiation; stochastic effects
references.citation: Trends Genet. 2006 Mar;22(3):165-73
references.pmid: 16446010
references.citation: Dose Response. 2011;9(4):444-64
references.pmid: 22461755
references.citation: Nat Rev Genet. 2008 Nov;9(11):831-42
references.pmid: 18852696
references.citation: Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30
references.pmid: 18270516
references.citation: PLoS Genet. 2006 Mar;2(3):e40
references.pmid: 16596166
references.citation: Cell Cycle. 2007 May 2;6(9):1001-5
references.pmid: 17457051
references.citation: Genes Dev. 2008 Apr 1;22(7):894-907
references.pmid: 18381893
references.citation: Cancer Res. 2009 Feb 1;69(3):1221-9
references.pmid: 19141645
references.citation: Genes Dev. 2007 May 1;21(9):1025-30
references.pmid: 17437991
references.citation: Trends Mol Med. 2006 Dec;12(12):580-7
references.pmid: 17071139
references.citation: Int J Cancer. 2007 Mar 1;120(5):953-60
references.pmid: 17163415
references.citation: Trends Immunol. 2008 Jul;29(7):343-51
references.pmid: 18515182
references.citation: Cancer Res. 2007 Feb 15;67(4):1419-23
references.pmid: 17308078
references.citation: Nat Rev Genet. 2004 May;5(5):396-400
references.pmid: 15143321
references.citation: Methods Mol Biol. 2006;342:19-32
references.pmid: 16957364
references.citation: Immunity. 2010 Jun 25;32(6):828-39
references.pmid: 20605486
references.citation: Proc Natl Acad Sci U S A. 1985 Apr;82(7):2092-5
references.pmid: 3856885
references.citation: Science. 2001 Sep 21;293(5538):2269-71
references.pmid: 11486053
references.citation: Oncol Rep. 2009 Oct;22(4):863-8
references.pmid: 19724866
references.citation: Nat Rev Mol Cell Biol. 2005 May;6(5):376-85
references.pmid: 15852042
references.citation: Proteomics. 2008 May;8(10):1975-9
references.pmid: 18491312
references.citation: N Engl J Med. 2005 Oct 27;353(17):1768-71
references.pmid: 16251533
references.citation: Cancer Res. 2005 May 1;65(9):3509-12
references.pmid: 15867338
references.citation: Cell Mol Life Sci. 2008 Feb;65(4):545-62
references.pmid: 17965831
references.citation: Cancer Res. 2008 Nov 1;68(21):9005-14
references.pmid: 18974146
references.citation: Mutat Res. 2011 Feb 10;707(1-2):24-33
references.pmid: 21159317
references.citation: PLoS One. 2009 Jul 27;4(7):e6377
references.pmid: 19633716
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: J Cell Biol. 1996 Dec;135(6 Pt 1):1643-54
references.pmid: 8978829
references.citation: Dose Response. 2006 Aug 28;5(1):39-47
references.pmid: 18648611
references.citation: Dose Response. 2010 Dec 14;9(1):59-75
references.pmid: 21431078
references.citation: Cell. 2009 Jan 23;136(2):215-33
references.pmid: 19167326
references.citation: Dose Response. 2009 Jun 11;7(2):104-31
references.pmid: 19543479
references.citation: Dose Response. 2011;9(4):579-601
references.pmid: 22461762
references.citation: Cell. 2005 Jan 14;120(1):15-20
references.pmid: 15652477
references.citation: Biol Chem. 2005 Dec;386(12):1205-18
references.pmid: 16336116
references.citation: Nat Cell Biol. 2008 May;10(5):593-601
references.pmid: 18376396
references.citation: RNA. 2004 Jul;10(7):1153-61
references.pmid: 15208450
references.citation: Cancer Cell. 2006 Jun;9(6):435-43
references.pmid: 16766263
references.citation: Cancer Res. 2011 Apr 15;71(8):3087-97
references.pmid: 21363915
references.citation: Cancer Res. 2007 Feb 15;67(4):1424-9
references.pmid: 17308079
references.citation: Nature. 2008 Sep 4;455(7209):64-71
references.pmid: 18668037